A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 270, 120708
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 40 references indexed in Scilit:
- Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the LiteraturePLOS ONE, 2013
- Th1 Cell Induction in Lymph Nodes According to a Red-Blue Chemokine MapImmunity, 2012
- Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel diseaseTherapeutic Advances in Gastroenterology, 2011
- Targeted minicircle DNA delivery using folate–poly(ethylene glycol)–polyethylenimine as non-viral carrierBiomaterials, 2010
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Folate Receptor β Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory MacrophagesCancer Research, 2009
- COX-2 Expression Correlates With Survival in Patients With Osteosarcoma Lung MetastasesJournal of Pediatric Hematology/Oncology, 2008
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug deliveryBiomaterials, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006